Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K

12.04.2024 - WOODCLIFF LAKE, N.J., April 12, 2024 (GLOBE NEWSWIRE) - Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company”) today announced that it received a notice (the “Notice”) on April 8, 2024 from the Listing Qualifications Department of The Nasdaq ... Seite 1

Related Keywords

, Nasdaq , Listing Qualifications Department Of Nasdaq , Nasdaq Hearings Panel The , Exchange Commission , Listing Qualifications Department , Nasdaq Stock Market , Eagle Pharmaceuticals Inc , Annual Report , Listing Rule , Quarterly Report , Initial Notice , Nasdaq Hearings Panel , Eagle Pharmaceuticals Chart , Agle Pharmaceuticals Kurs , Agle Pharmaceuticals Aktie ,